a Programa de Pós-Graduação em Ciências Farmacêuticas, Centro de Ciências da Saúde , Universidade Federal de Santa Maria , Santa Maria-RS , Brazil.
b Programa de Pós-Graduação em Bioquímica Toxicológica, Centro de Ciências Naturais e Exatas , Universidade Federal de Santa Maria , Santa Maria-RS , Brazil.
Redox Rep. 2017 Nov;22(6):451-459. doi: 10.1080/13510002.2017.1288973. Epub 2017 Feb 16.
This study was conducted to assess the markers of oxidative stress, myeloperoxidase (MPO), acetylcholinesterase (AChE) and xanthine oxidase (XO) activities as well as the levels of nucleotide metabolites in sickle cell anemia (SCA) patients.
Fifteen SCA treated patients and 30 health subjects (control group) were selected. The markers of oxidative stress (levels of reactive oxygen species (ROS), plasma proteins, carbonyl content, lipid peroxidation (TBARS), total thiols (T-SH), glutathione and catalase activity), MPO, AChE and XO activities as well as the levels of nucleotide metabolites were measured in SCA patients.
ROS, thiobarbituric acid-reactive substances (TBARS) and T-SH levels as well as the activities of catalase and MPO were significantly increased while glutathione level was reduced in SCA patients. Furthermore, a significant (P < 0.001) increase in hypoxanthine level was demonstrated in SCA patients. However, the serum levels for xanthine (P < 0.01) and uric acid (P < 0.001) were decreased in SCA patients. A significant (P < 0.001) decrease in XO activity was detected in SCA patients.
The altered parameters in SCA patients suggest that the generation and impairment of oxidative stress in this disease as well as antioxidant markers are contributory factors towards cellular redox homeostasis and alteration of purine metabolites.
本研究旨在评估氧化应激标志物、髓过氧化物酶(MPO)、乙酰胆碱酯酶(AChE)和黄嘌呤氧化酶(XO)活性以及核苷酸代谢物水平在镰状细胞贫血(SCA)患者中的变化。
选择 15 例 SCA 治疗患者和 30 名健康受试者(对照组)。检测 SCA 患者氧化应激标志物(活性氧(ROS)水平、血浆蛋白、羰基含量、脂质过氧化(TBARS)、总巯基(T-SH)、谷胱甘肽和过氧化氢酶活性)、MPO、AChE 和 XO 活性以及核苷酸代谢物水平。
ROS、硫代巴比妥酸反应物质(TBARS)和 T-SH 水平以及过氧化氢酶和 MPO 活性显著升高,而 SCA 患者的谷胱甘肽水平降低。此外,SCA 患者的次黄嘌呤水平显著升高(P < 0.001)。然而,SCA 患者的黄嘌呤(P < 0.01)和尿酸(P < 0.001)血清水平降低。SCA 患者的 XO 活性显著降低(P < 0.001)。
SCA 患者的改变参数表明,该疾病中氧化应激的产生和损伤以及抗氧化标志物是细胞氧化还原平衡和嘌呤代谢物改变的促成因素。